We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+20.89%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.13B
AUM Growth
+$563M
Cap. Flow
-$172M
Cap. Flow %
-2.8%
Top 10 Hldgs %
24.72%
Holding
175
New
20
Increased
65
Reduced
40
Closed
23

Top Buys

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$59.7M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$54.7M
3
LXEO icon
Lexeo Therapeutics
LXEO
+$37.3M
4
MNDY icon
monday.com
MNDY
+$32.9M
5
XMTR icon
Xometry
XMTR
+$28.5M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$79.8M
2
EXAS
Exact Sciences
EXAS
+$51.4M
3
SHLS icon
Shoals Technologies Group
SHLS
+$42.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$39.3M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$39.2M

Sector Composition

Rank Sector Weight
1 Healthcare 39.38%
2 Technology 24.68%
3 Industrials 16.87%
4 Consumer Discretionary 8.76%
5 Communication Services 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
26
DELISTED
Exact Sciences
EXAS
$80.1M 1.31%
1,083,313
-784,737
-42% -$51.4M
MIRM icon
27
Mirum Pharmaceuticals
MIRM
$6.87B
$78.6M 1.28%
2,663,649
-1,294,930
-33% -$39.2M
TMDX icon
28
Transmedics
TMDX
$2.63B
$78.5M 1.28%
994,240
+68,884
+7% +$4.16M
MNDY icon
29
monday.com
MNDY
$3.73B
$76.6M 1.25%
407,870
+204,253
+100% +$32.9M
COUR icon
30
Coursera
COUR
$1.51B
$76.3M 1.25%
3,937,804
+243,894
+7% +$4.66M
TTD icon
31
Trade Desk
TTD
$8.59B
$74.2M 1.21%
1,030,889
+18,247
+2% +$1.34M
TREX icon
32
Trex
TREX
$4.56B
$73.1M 1.19%
882,588
+58
+0% +$3.85K
DV icon
33
DoubleVerify
DV
$1.69B
$70.6M 1.15%
1,920,539
+11
+0% +$343
APTV icon
34
Aptiv
APTV
$12.3B
$70.5M 1.15%
785,473
+792
+0.1% +$68.2K
LRCX icon
35
Lam Research
LRCX
$372B
$67M 1.09%
855,490
-303,720
-26% -$20.7M
TOST icon
36
Toast
TOST
$19.1B
$66.7M 1.09%
3,650,066
+723,992
+25% +$11.9M
ENTG icon
37
Entegris
ENTG
$17.8B
$64.3M 1.05%
536,977
+29,347
+6% +$2.98M
MPWR icon
38
Monolithic Power Systems
MPWR
$64.7B
$62M 1.01%
98,333
+9
+0% +$4.7K
KRTX
39
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$60.1M 0.98%
190,000
-149,840
-44% -$29.1M
FIVN icon
40
FIVE9
FIVN
$2.12B
$55.4M 0.9%
703,551
+9,498
+1% +$661K
ASML icon
41
ASML
ASML
$634B
$52.9M 0.86%
69,848
-43
-0.1% -$28.4K
LNG icon
42
Cheniere Energy
LNG
$54.1B
$51.4M 0.84%
301,223
+8
+0% +$1.38K
AURA icon
43
Aura Biosciences
AURA
$735M
$51.4M 0.84%
5,802,682
+2,777,777
+92% +$23.5M
MRNS
44
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$49.2M 0.8%
4,529,997
– –
CYTK icon
45
Cytokinetics
CYTK
$10.9B
$46.4M 0.76%
556,000
– –
NVT icon
46
nVent Electric
NVT
$23.4B
$45.4M 0.74%
769,097
-18,820
-2% -$998K
KLAC icon
47
KLA
KLAC
$236B
$45.4M 0.74%
780,950
+110,600
+16% +$5.76M
BILL icon
48
BILL Holdings
BILL
$4.52B
$42.7M 0.7%
523,115
+339,901
+186% +$27.9M
ARDX icon
49
Ardelyx
ARDX
$1.25B
$42.2M 0.69%
6,805,494
+4,110,494
+153% +$18.4M
TRGP icon
50
Targa Resources
TRGP
$57.6B
$41.5M 0.68%
477,662
-96,992
-17% -$8.33M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Eventide Asset Management held 175 positions worth $6.13B, up 10% from $5.56B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q4 2023 filing shows 20 new, 65 increased, 40 reduced and 23 closed positions. Its largest new stake was Lexeo Therapeutics: 3,002,831 shares worth $40.3M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $79.8M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2023 buy was Lexeo Therapeutics: 3,002,831 shares worth $40.3M.
  • Eventide Asset Management added most to Celldex Therapeutics in Q4 2023, an estimated $59.7M increase.
  • Eventide Asset Management's biggest Q4 2023 reduction was Exact Sciences, cutting an estimated $51.4M.
  • Eventide Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $79.8M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $6.13B portfolio in Q4 2023.
  • Eventide Asset Management opened 20 new positions and closed 23 in Q4 2023.
  • Eventide Asset Management's portfolio value rose 10% quarter-over-quarter to $6.13B.

Based on Eventide Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.